40 Flashcards
Infant HIV testing
HIV DNA PCR at 48hrs, 4-6wk, 3 mo
HIV Ab at 12-18 mo
new HIV labs
CBC, LFT, BUN/creat, urinalysis, hepatitis serologies, blood glucose, lipids, genotypic resistance, STIs, opportunistics (toxo, CMV, PPD)
Preventive Txt PCP in HIV
CD4 <200 DS Bactrim daily
Preventive Txt Toxoplasmosis in HIV
CD4 <100+toxo Ab DS Bactrim daily
Preventive Txt MAC in HIV
CD4<50 Azithro or clarithro weekly
Routine Vaccines in HIV
pneumovax if CD>200, HAV, HBV, flu
screen for HBV, HCV
HIV Treatment based on CD4 count in adult
Treat CD4500 (WHO defer until <350)
HIV Meds
entry inh (fusion inh, CCR5 blockers), NRTIs, NNRTIs, integrase inh, protease inh
HIV med drug interaction
inhaled steroids, statins, methadone, OCPs, rifampin, erectile dysfunction, st johns wort, PPIs, coumadin
Protease Inh drug interactions
HIGH RISK/CI - simvastatin, lovastatin
mod risk - fibrate+statin, atorvastatin
low risk - fibrates, pravastatin, fluvastatin, rosuvastatin, fish oil, niacin
HBV, HCV, HIV avg transmission rates
HBV 30% > HCV 3% gt HIV 0.3%
Occupational exposure risks
IM injury 16% > advanced AIDS source pt 6% > visible blood on device/needle enter blood vessel 5% >AZT PEP 0.2%
Post-exposure prophylaxis - occupational and non occ
3 drug therapy, 28 days, immediate start to meds important
reduces risk 81%
Post-exposure F/U testings
Initial - CBC, creat, LFT, HIV Ab, HCV Ab, HBsAg/Ab
2 weeks - CBC, creat, LFTs
6 weeks - HIV ab, HCV ab, RPR
3 mo+6mo - HIV ab, HCV ab (stop at 3 mo if using p24 ab test)
Pre-exposure prophylaxis
Truvada daily
risk reduction 44%, up to 90%
Pre-exposure prophylaxis pre-initiation testing
Test for HIV ab, CrCl>60
screen and vaccinate HBV
screen and treat STDs
Pre-exposure prophylaxis F/U
F/u - q3mo - HIV ab, STD sx eval, counsel
q6 mo - STD test even is asymp
BUN/creat 3 mo post start then annually
HIV incubation period
2-4 weeks
Acute retroviral syndrome timing
2-4 weeks post exposure, lasts 3-14 days
Acute retroviral syndrome Sx
fever, rash, swollen lymph - high viremia
HIV tests
*Elisa - negative until >3-4wk post infection
P24 - 3 weeks
HIV RNA - +10-15 days post infection
- use unless suspect acute retroviral syndrome
HIV Clinical Latency Sx, tests, duration
HIV ab response - cell mediated then humoral
Symptoms - none
Tests - Elisa+ HIV RNA+
Duration - variable
Viral set point HIV
predictor of dx - set 3-6 mo post infection
high set point - high rate of transmission
Symptomatic phase - CD4 related dx’s
Progression to AIDS
CD4<500 - bacterial pneumo, TB, minor skin infections more common
CD4 200-500 - opportunistic infections - herpes zoster, TB, candidiasis, PCP, toxo, CMV, kaposi, HSV
HIV Screening Guidelines
All persons 15-65 - once
High risk pts - annually
Pregnant women - once, again in 3rd tri if high risk area
written consent not required
TB presentations - types
pulmonary, pleural, pericardial, GI, lymphnode, GU, skeletal (gibbus malformation, Potts dx)
TB symptoms
Chronic cough >2-3 weeks, night sweats, loss of appetite, weight loss/consumption, fatigue
TB exam findings
nonpainful cervical LAN
TB testing
PPD, CXR, interferon gama release assay IGRAs, sputum AFB smear and culture, fluid exam in localized dx, tissue pathology, ab and antigen detection assays
TB testing shortcomings
CXR negative in 50% children w/ active TB
sputum smear 50% reliable, only possible children>10
PPD - limited sensitivity in HIV/TB coinfected
TB First Line Treatments
2 months - rifampin, isoniazid, pyrazinamide, ethambutol
continuation phase - 4 months rif, INH
TB Second Line Treatments
12-18 month therapy
ethionamide, cycloserine, para-aminosalacylic acid, quinolones
Injectables: streptomycin, capreomycin, kanamycin, amikacin
MDR-TB
resistant to INH and rifampin
XDR-TB
resistant to INH, rifampin, AND fluoroquinolone AND one of the injectables (capreomycin, kanamycin, amikacin)
MDR-TB Treatment Options
Minimum of 4 drugs, 1 year treatment
quinolones - moxiflox, levoflox, gatiflox)
aminoglycosides- streptomycin, capreomycin, kanamycin)
other - pyrazinamide/PZA, cycloserine, ethionamide, PAS
Risks of HIV/TB coinfection
Increased progression latent to active TB
more rapid HIV dx progression
higher TB relapse rates
higher rates MDR and XDR-TB
Benefit of HIV/TB cotreatment
reduced TB deaths, HIV pts less likely to get TB, lower mortality
Risks of HIV/TB cotreatment
Interactions between drugs alter levels –> can lower PI and NNRTI and cause drug failure
Combined SE intolerable
Many many daily doses
HIV/TB cotreatment recommendations
Adults/pedi - start TB txt first, start ART asap w/i 8 weeks as tolerated, irrespective of CD4 count
Adult - use EFV as preferred NNRTI
TB Preventions
Age treat
Txt latent TB
BCG vaccination
isolation, treatment, contact tracing
LTBI
No S+S, can’t spread
Positive - TST, IGRA
Negative - CXR, respiratory smear and culture
Txt to prevent conversion to active TB - INH
Active TB
S+S - fever, cough, chest pain, weight loss, night sweats, hemoptysis, fatigue, decreased appetite
Positive - TST, IGRA, CXR (may be normal in adv immunosuppression), respiratory smear and culture (may be - in pulmonary dx)
Txt NEEDED
TB Screening Guidelines
Risk - sx TB, healthcare field, spend time around infectious, travel to TB endemic area, poorly functioning immune system
Tuberculin skin test readings
> 5mm - HIV or HIV unknown + IVDU, close contact active TB, fibrotic CXR lesions, on steroids, transplant pt
10mm - IVDU and HIV-, high prevalence country, medically underserved, long term care facility
5mm - no increased risk
20% w/ active TB and 80% with active TB and HIV test negative
Latent TB treatments
INH daily/BIW for 9 mo
Rif 4 mo
Rif/PZA 2 mo - ONLY IF HIV+
LTBI w/ Drug resistant TB exposure treatments
INH resistant exposure - rif 4 mo or rif/PZA 2 mo
MDR exposure - EMB+PZA or quinolone+PZA
LTBI treatment - Pregnant
INH for 9 mo - can delay txt
NO DELAY IF HIV+ OR NEWLY EXPOSED
Immune Reconstitution Inflammatory Syndrome IRIS
clinical deterioration after starting combo ART
immune system starts working and causes inflammation against infection
weeks - 6 mo after ART initiation (mean 21d)
ARV continued until TB meningitis
Prednisone 2-4mg/kg/day
Migraines criteria
2 or more: 4-72hrs, unilateral, pulsating, mod to severe, aggravate by activity
1 or more: N, V, photophobia, phonophobia
w/ or w/o aura
Dx - 5 or more HAs that meet criteria
Chronic Migraine
Migraine for >=15 days/mo for >3mo
Tension type
Bilateral, pressing, tightening, mild to mod, NOT aggravated by activity, no N/V, either phono or photophobia
Chronic Tension type HAs
TTH for >=15 days/mo for >3mo
Cluster HA
severe unilateral orbital/supraorbital/temporal pain lasting 15m-3h
1 or more: ipsilateral conjuntival injection or lacrimation, ipsilateral nasal congestion/rhinorrhea, ipsilaterl eyelid edema, ipsilateral miosis/ptosis, restlessness/agitation/pacing
Often at night, wake up from sleep, tend to cluster
Cluster HA risk factors
Male, middle aged, assoc w/ ETOH, smoking
Cluster HA Imaging
CT if first one since symptoms so severe
If hx cluster, only treat
Primary stabbing HA
ice pick HA, <1sec, quick and repetitive, cluster, almost never serious, reassurance best
prophylactic ibuprofen if needed
Hypnic HA
wake ppl up from sleep, >50yrs
Daily persistent HA
HA for >3mo, daily/unremitting from onset, definite start date
Sx - bilateral, pressing/tightening, mild to mod, not aggravated by activity
Only 1 of following: photo, phonophob, N
No severe N/V
Imaging: usually
Txt: chronic pain management
Migraine location, characteristics, pt appearance, duration, assoc sx
- unilateral, bifrontal, global 30%
- gradual onset, crescend, pulsating, mod-sev, worse w/ activity
- rest, dark, quiet room
- 4-72 hr
- N/V/photo/phonophob/aura
TTH location, characteristics, pt appearance, duration, assoc sx
- Bilateral
- pressure, tightness, waxes and wanes
- Active or resting
- variable duration
- no assoc sx
Cluster HA location, characteristics, pt appearance, duration, assoc sx
- unilateral, around eye/temple
- rapid onset, crescendo w/i minutes, deep, continuous, excruciating pain
- active pt
- 30m-3h
- Sx - ipsilateral lacrimation/redness, stuff nose, rhinorrhea, pallow, sweating, Horner’s syndrome, focal neuro sx rare, sensitivity to ETOH
HA redflags
fever, stiff neck, sudden severe HA (onset and terrible w/i 1 sec), worst HA of life, new onset HA >50y, abnormal neuro, hx head trauma w/i 1 wk, HIV+ or risk, Hx cancer, increasing severity or changed character
IHS secondary headache classifications
head/neck trauma, cranial vascular d/o, non-vascular intracranial d/o, substance or withdrawal, infection, homeostasis disruption, cranium, neck, eyes, ears, nose, sinus, teeth, mouth, facial d/o, psych d/o
Temporal arteritis/giant cell arteritis Sx
Person > 50 w/ piercing, throbbing, localized HA
scalp tenderness, +/- temporal tenderness, low grade fever, anorexia, weight loss, malaise, jaw claudication, +/- PMR sx, visual sx (ask abt PMR sx - often assoc)
Temporal Arteritis Tests
ESR >50 (or CRP) - can have near normal ESR, still tret
Temporal artery biopsy - gold standard
Temporal Arteritis Treatment
60 mg prednisone daily - start ASAP and stop if biopsy -
Headache relevant PMH
HTN, HIV, thyroid, ca, depression, head trauma, dental work, recent medical procedures
Diagnostics needed: >50 new onset HA
ESR, CT
Diagnostics needed: young women, migraine criteria, normal neuro
no imaging
check TSH
if triptan helps –> basically diagnostic
Diagnostics needed: young heroin addict, new onset
CT + LP - brain abscess risk
Diagnostics needed: hx cancer
CT - mets
Diagnostics needed: HA, fever, rash
LP - meningitis, lymes
Diagnostics needed: elderly, fell
CT w/ neck - subdural, fx
Diagnostics needed: aspirin, coumadin
CT - brain bleed
Diagnostics needed: new HA, papilledema
CT
Diagnostics needed: kids, concerning HA
MRI instead b/c radiation concern
Tension type HA treatment
acetaminophen, NSAIDS, fioricent (habit forming, rebound HAs, dizzy, sedation), muscle relaxants (soma, skelaxin, flexeril)
prophylactic if freq occurrence
Cluster HA treatment
avoid triggers - etoh, tobacco O2 - NRB 12L high dose NSAIDS 1000mg-1200mg motrin ergotamines, triptans prophylactic if freq occurrence
Migraine HA treatment - nonpharm
HA diary, regulr sleep, exercise, eating patterns, avoid triggers, stress management, massage, DC offending agents (OCP, CCB)
Migraine HA treatment - pharm
excedrin migrain - asa, acetaminophen, caffeine
ergotamines, triptans, narcotics (avoid), glucocorticoids (can break bad HA cycle), antiemetics, metoclopromide
Migraine Prophylactic treatment
> 2HA/wk, interfere w/ life, abortive txt issues
BB - 20mg inderal BID, up to 40mg
CCB - 20mg verapamil qHS
TCA - 25 mg amitriptyline qHS
Antiseizure - valproate, topiramate - neurologist
Common HA triggers
food, hormonal, sensory, stress, environment changes, schedule changes
Ergotamine - cafergot, migranal
Oral, sublingual, infectable, nasal spray
MOA - vasoconstriction
CI - pregnancy, heart dx, PVD, can cause vasospasm: raynauds, periph vasc ischemia
NOT w/ ketoconazole, macrolides - periph ischemia
24 hours APART FROM TRIPTANS
Triptans - 5HT serotonin receptor agonist
zomig, maxalt - short T 1/2
amerge, frova - long T 1/2
imitrex, relpax, axert – diff meds work well for diff ppl
SC, nasal, tabs
MOA - intracranial vasoconstriction, reduce edema, decrease inflammatory peptide influx, block trigeminal complex pain transmission
CI - pregnancy, CAD, angina
SE - facial flushing, tingling of skin, tightness around chest/neck
serotonin syndrome - decreased dose if w SSRI - confusion, sweating, diarrhea, tremor, high BP
24 hours APART FROM ERGOTAMINES
Focal/partial seizure
Starting in one hemisphere
simple seizure
consciousness maintained
Generalized seizure
starts in both hemipheres, LOC, no aura, +/-convulsions
Types of generalized seizures
absence - LOC, starring spells atypical absence - LOC, change of tonie, automatisms myoclonic - jerking, flexing/unflexing tonic - stiffening/extended atonic - drop attacks
Idiopathic epilepsy
underlying genetic cause, start in infant/early childhood
normal development, normal neuro exam, no neuro d/o
Idiopathic epilepsy types
chronic absence - 5-10yrs, outgrows
benign rolandic - 5-15yrs, nocturnal sx
benign occipital - confused w/ migraines, EEG finding
juvenile myoclonic - starts at puberty
Paroxysmal seizure - test to run
labs - glucose, Mg, Ca, CBC, urine tox
EEG
LP - not necessary w/ 1st nonfebrile, only if concern
MRI - structural abnormalities, tumors, vascular abn
Epilepsy Dx in Child
> =2 unprovoked seizures or 1 unprovoked w abn EEG
Epilepsy Treatment Protocol
goal: monotherapy
Before starting: CBC, platelets, LFTs, amylase/lipase - monitor blood work q 3mo
Epilepsy Narrow Spectrum Meds
dilantin, phenobarb, tegretol, trileptal, gabapentin, vimpat, sabril
cover partial, focal, absence, myoclonic seizures
Epilepsy Broad Spectrum Meds
depakote, lamictal, topamax, zonegran, keppra, klonopin, banzel
covers wide variety of seizures - plus absence/myoclonic
Meds for localized and complex partial seizures
Tegretol, depakote, topamax, dilantin, lamictil, tripleptil, keppra
Generalized seizures meds - absence
ethosuximide, valproic acid
Generalized seizures meds - primary generalized tonic clonic
topamax, trileptal
Febrile seizures in children
Seizure w/ febrile illness, >1 mo, <6yrs
No CNS infector or e- imbalances. No previous afebrile sz
Complex febrile seizure
> 10-15min, focal, multiple with same illness
Simple febrile seizure
<10min, non-focal
Febrile sx risk factors
family hx febrile sz 1st and 2nd relative, developmental delay, neonatal nursery stay >30 days, daycare attendance
Risk NOT related to temp #
Simple Febrile Sz LP decision
YES LP if 5
NO LP - >18mo w/ hx and PE not suspicious
Complex Febrile Sx LP decision
YES LP - prolonged duration, focal
MAYBE LP - multiple seizures in same illness
Risk for meningitis w/ febrile sz
focal or prolonged sz, abnormal findings on neuro or PE, seizure later in illness
AAP Guidelines Febrile Seizure Diagnostics
LP - strongly recommended w/ meningeal signs (not if fever source known)
EEG - not routine if neuro healthy
E-, Ca, phos, mg, glucose, cbc - not routine
neuroimaging - not recommended for routine eval simple febrile
Febrile Status Epilepticus
febrile seizure >30 min
Febrile Sz Prevention
NONE recommended
Diazepam/diastat rectally at start of seizure
Diazepam/diastat PO or rectally w/ febrile illness, SE higher than benefit
antipyretic ineffective
Concussion S+S
confusion, amnesia, HA, V, dizziness, (LOC uncommon)
post: cognitively slow, emotionally irritable, drowsy
Best predictor of protracted recovery
Dizziness post concussion
Treatment
cognitive and physical rest - neuropsych testing
Pedi Headaches Presentation
irritable, N, V, lack of appetite, fatigue
Pedi Headache management
HA diary (diet and social), tylenol, ibuprofen, Mg vitamin
Age of closure of epiphyseal growth plate, hormone responsible
20yrs, estrogen/testosterone
Limp from Infection
acute, localized, severe (no weight bearing), fever, high WBC, ESR, CRP
Limp from Inflammation
chronic, insidious onset, rash, involve other joints, usually weight bearing (except transient synovitis)
Limp for Orthopedic Problem
localized pain to hip, can be referred to thigh/knee, acute or insidious onset, pain increase with activity, decreased with rest, systemic sx absent, ESR/CRP normal
Limp for Neoplasm
worse at night, unrelated to activity, may have systemic sx, labs abnormal (anemia, leukopenia, thrombocytopenia)
anterior knee pain, increased gradually, pain worse w direct trauma, squatting, climbing stairs, uphill, relieved by rest
Osgood Schlatter
Osgood Schlatter risks
age 9-14, rapid growth spurt, active in sports, boys
Osgood Schlatter treatment
Pain control, reduce swelling - ice, NSAIDs for 3-4d, protective pad over tubercle
Don’t need to avoid sport, no f/u needed
Resolve when plate ossifies, 18-20y
Displacement of capital femoral epiphysis from femoral neck through epiphyseal plate
Slipped capital femoral epiphysis
hip pain, nonradiating, dull aching in hip, groin, thigh, knee, no hx trauma, pain may increase w activity or may be acute, chronic, intermittent antalgic gait (limp, fixed knee, walk on side of foot)
Slipped capital femoral epiphysis
Slipped capital femoral epiphysis risks
teens and preteens, obese
Slipped capital femoral epiphysis Exam finding
decreased IR, abd, flexion
Slipped capital femoral epiphysis Tests
MRI (Xray preferred initial diagnostic) –> ortho
Most common nontraumatic hip pain in children
transient synovitis
pain and LROM, antalgic gait, hip in abduction, external rotation, no precipitant and resolves gradually, no fever, nontoxic appearing, WBC<2, unilateral or bilateral joint effusion
transient synovitis
hip pain, fever
think septic arthritis
transient synovitis treatment
NSAIDS and return to full activity as tolerated
Full recovery 1-4wks
Can have prior symptoms of V, D, cold/runny nose, URI, pharyngitis, bronchitis, AOM in 1/2 of case
transient synovitis
transient synovitis risks
age 3-8, M>F, fall/winter season, afebrile, well appearing
Scoliosis criteria
> 10 degree curvature laterally
Types of scoliosis
- -neuromuscular - 2nd to MS problem - CP, neurofibromatosis, marfans
- -congenital - 2nd to congenital abn - hemivertebra - manifests BEFORE adolescence
- -idiopathic -most common, no known etiology
Scoliosis tests
Adams forward bend test, scoliometer/inclinometer
Scoliosis management
10-20d –> exercises to improve posture/muscle/strength
20-40d –> bracing, boston brace, 23 hr/day
40-50d –> spinal fusion surgery
Overuse syndrome
microtrauma of tissue
Febrile infant 100.4
septic work up to r/o serious bacterial infection –> ER
bacteremia S+S
irritability, poor feeding, change in sleep pattern, often no localized sx
Toxic appearing infant Sx
irritabile, inconsolable, poor perfusion, poor tone, lethargy
Septic workup, <3mo
Blood culture, CBC w diff, U/A + culture
CSF - count and diff, culture, gram stain, glucose, protein
CXR if respiratory sx
Stool culture if D
Febrile infant <3mo, w/ negative septic work up Txt
IM ceftriaxone, f/u for 2nd dose, await culture
Child 3-36 mo, likely pathogen
S pneumo, S aureus, N menigitidis, H influenza
Work up - febrile infant, 12mo-36mo, non toxic appearing
No septic work up required
work up - child w fever as presenting sx
CBC w diff, U/A, throat culture, blood culture (maybe CXR, LP)
work up - child w fever, abd pain, n/v
CBC w diff, U/A + culture, abd CT scan
Bacterial infection lab changes
increase neutrophils and bands – left shift
WBC in allergies, asthma
basophils (histamine release)
eosinophils (parasites/drug sensitivity)
No response to bacterial/viral infection
WBC that increases during recovery from illness
monocytes - increase in pneumonia, mono, varicella
Viral infection lab changes
increase in lymphocytes and monocytes – right shift
also seen in tissue breakdown, burns, allergies, lymphocytic leukemia
Reasons high milk consumption can lead to anemia
cow protein causes microscopic blood loss in stool, full on milk and not eating enough iron, bioavailable iron in milk is low
Normal WBC
5000-10000
Normal RBC
4.5-5.5
Normal neutrophils
54-62%
Normal bands
3-5%
Normal HGB
11.5-15.5
Normal HCT
35-45%
Normal platelets
150-400K
Normal MCV
80-100 (77-95)
Normal MCHC
31-37%
Normal Retic count
0.5-1.5
Normal RDW
11.5-14.5
Normal Eosinophils
1-3%
Normal Basophils
0-0.75%
Normal lymphocytes
25-33%
Normal monocytes
3-7%
Test to Dx UTI
C+S - >100 in clean catch, >50 in cath
Most specific U/A result for UTI
nitrites
diet high in citrus fruits/veggies make urine..
alkaline
diet high in meat, cranberry juice make urine…
acidic
Parkinsons risks
men, 55-65
Parkinson cardinal features
akinesia, bradykinesia, cogwheel rigidity, unstable posture, resting tremor
Typical 1st Sx Parkinsons
resting tremor - pill rolling - usually do well for 10 yrs if major sx
(late sx in parkinsonian like sx but not parkinsons)
Other parkinsons Sx
freezing of gait, micrographia, low pitched indistinct speech, decreased blinking, reduced facial expression, seborrhea, depression anxiety, memory loss, impaired judgment, poor planning, sleep issues b/c of bradykinesia, sexual/urinary/bowel dysfunction
Parkinsons cause of death
choking, falls, pneumonia
Parkinsons cause
neurodegen of dopamine containing neurons in substantia negra
dopamine from basal ganglia controls movement
symptoms when 50-80% loss of dopamine
Parkinsons diagnostic tests
None, imaging to r/o other conditions - PET, SPECT, CT
– imaging if early balance/gait d/o’s, not responsive to levodopa, imaging shows structural involvement other than basal ganglia
Surgical parkinsons tx
thalatomy, pallidotomy, deep brain stimulation
Parkinsons tx pharm
respond well for 3-5 years then end of dose effects, dyskinesthias
help sx, doesn’t stop dx progression
Dopamine agonist - mirapex, requip
parkinsons - 1st drug prescribed, activates brain dopamine receptors
Dopamine precursor, levodopa
parkinsons - 2nd txt - MAINSTAY OF TXT - can lead to drug induced dyskinesias, impaired judgment
Parkinsons meds
dopamine agonist, dopamine precursor, decarboxylase inh, catechol methyltransferase inh, copamine releaser, dopamine receptor blocker, type B MAO, anticholinergics
decarboxylase inhibitor, carbidopa
parkinsons - given w/ levodopa, prevents metabolism of levodopa - reduces SE of N,V of levodopa
catechol-o-methyltransferase inhibitor - entacapone/comtan
parkinsons - other site in pathway, well tolerated, often given w/ sinemet
dopamine releaser, amantadine
parkinsons - helps release dopamine more effectively, brief effect